Omega Flex, Inc. quarterly report, Q1 FY2021

Omega Flex, Inc. — Q1 2021 Form 10-Q Summary

Business Context and Reporting Period

Omega Flex manufactures and sells flexible metal hose, proprietary fittings, and accessories for residential and commercial construction, industrial, transportation, petrochemical, pharmaceutical, medical, and other applications. The company operates as one segment, with manufacturing facilities in Pennsylvania, Texas, and the United Kingdom, and sells primarily through distributors, wholesalers, sales representatives, and OEMs.

This unaudited quarterly report covers the three months ended March 31, 2021, compared with the three months ended March 31, 2020. The filing was signed May 7, 2021.

Financial Performance and Position

MetricQ1 2021Q1 2020Change
Net sales$30.863 million$25.266 millionUp 22.2%
Gross profit$19.559 million$15.769 millionUp 24.0%
Gross margin63.4%62.4%Up 1.0 percentage point
Operating profit$8.319 million$5.845 millionUp 42.3%
Operating margin27.0%23.1%Up 3.9 percentage points
Net income$6.297 million$4.366 millionUp 44.2%
Net income attributable to Omega Flex$6.267 million$4.344 millionUp 44.3%
Basic and diluted EPS$0.62$0.43Up $0.19

Sales growth was driven primarily by higher unit volume and, to a lesser extent, pricing actions intended to offset material-cost pressure. Cost of goods sold increased to $11.304 million from $9.497 million.

  • Selling expense increased 5.9% to $4.821 million, primarily from higher freight, commissions, staffing, and advertising, partly offset by lower travel and trade-show costs.
  • General and administrative expense increased 27.4% to $5.418 million, principally because of higher incentive compensation, including phantom-stock expense, and higher director fees.
  • Engineering expense decreased 10.6% to $1.001 million, partly because of lower travel costs.
  • Income tax expense increased 44.7% to $2.049 million. The filing does not provide a clear reported effective tax rate.
  • Cash dividends declared were $0.28 per common share, consistent with Q1 2020.

Cash Flow, Liquidity, Debt, and Balance Sheet

MetricMarch 31, 2021December 31, 2020
Cash and cash equivalents$22.674 million$23.633 million
Total assets$70.177 million$71.571 million
Total liabilities$20.291 million$25.194 million
Total shareholders’ equity$49.886 million$46.377 million
Accounts receivable$19.718 million$20.077 million
Inventory$11.949 million$11.510 million
  • Operating activities provided $2.207 million of cash, compared with $0.751 million in Q1 2020.
  • Capital expenditures were $0.362 million, compared with $0.145 million in the prior-year quarter.
  • Dividends paid were $2.826 million. Cash decreased by $0.981 million during the quarter, after a $22,000 favorable currency translation effect.
  • The company had no borrowings under its unsecured $15 million revolving credit facility and was in compliance with all debt covenants.
  • Management stated that cash and available borrowing capacity should be sufficient to meet anticipated needs for at least the next twelve months.
  • Current liabilities declined to $17.639 million from $21.871 million, primarily because year-end accrued compensation was paid during the first quarter. Taxes payable increased to $2.726 million from $0.979 million.

Material Changes Versus the Prior Comparable Period

Compared with Q1 2020, the company reported substantially higher sales, profit, operating cash flow, and margins. Management stated that Q1 2020 sales were partially impeded by the COVID-19 pandemic. Pricing actions helped address material-cost pressure while gross margin improved.

Profitability benefited from operating leverage and lower selling and engineering expenses as a percentage of sales. However, general and administrative costs rose faster than sales, primarily because of incentive compensation. Phantom-stock compensation changed from $0.467 million of compensation income in Q1 2020 to $0.441 million of expense in Q1 2021, largely reflecting changes in the company’s stock price.

Outlook, Risks, Contingencies, and Unusual Items

  • No formal revenue or earnings guidance was provided.
  • Management identified future capital needs as dependent on revenue growth, expansion, potential acquisitions or capacity investments, and the continuing impact of COVID-19.
  • A prolonged COVID-19 pandemic could trigger a goodwill impairment test, although no triggering event had occurred through March 31, 2021.
  • One customer represented more than 10% of accounts receivable and more than 10% of sales in both comparable periods, creating customer-concentration risk. Sales are also concentrated in the United States.
  • The company faces product-liability claims relating primarily to alleged lightning damage involving its flexible gas-piping products. The estimated aggregate maximum exposure for open claims within applicable insurance deductibles or retentions was approximately $4.3 million; recorded liabilities were $0.340 million at March 31, 2021.
  • The company states that it cannot estimate the ultimate liability, if any, from pending or future claims. Insurance deductibles or retentions generally range from $25,000 to $2.0 million per claim.
  • A previously disclosed Missouri putative class action was dismissed, and the plaintiffs’ appeal was resolved, concluding the matter.
  • The company paid £320,000 during Q4 2020 in connection with a United Kingdom legal dispute; only a nominal liability remained at March 31, 2021.
  • The United Kingdom Banbury facility lease became month-to-month after its March 2021 expiration and was under negotiation for renewal.
  • The company’s $2.453 million PPP loan received in April 2020 was fully repaid by May 7, 2020.
  • The company is discussing the transition of its revolving-credit interest-rate reference from LIBOR to a replacement rate such as SOFR.
  • Management reported effective disclosure controls and no material changes to internal control over financial reporting. No additional risk factors were identified for the quarter beyond those in the 2020 Form 10-K.

Important Facts for Investors to Verify

  • Whether sales volume and pricing gains remain durable after the COVID-19-related comparison benefit in Q1 2020.
  • The effect of raw-material inflation, freight costs, supply availability, and future pricing actions on gross margin.
  • The magnitude and timing of phantom-stock and other incentive-compensation expenses.
  • The status, settlement costs, and insurance coverage of product-liability claims, including potential exposure up to the disclosed approximately $4.3 million aggregate amount.
  • The renewal terms and future cost of the Banbury facility lease.
  • The identity and continuing significance of the customer representing more than 10% of sales and accounts receivable.
  • The company’s dividend policy and capacity to fund dividends while maintaining cash reserves and capital expenditures.
  • The timing and terms of any LIBOR-to-SOFR or other reference-rate transition under the revolving credit facility.